# Impact of methicillin-resistant Staphylococcus aureus surveillance and decolonization in the NICU: the Texas children’s hospital experience

**Authors:** Nahid Hiermandi, Catherine Foster, Judith Campbell, Krystal Purnell, Elizabeth Tocco, Tjin Koy, Kenneth Nobleza, Duc Nguyen, Lucila Marquez

PMC · DOI: 10.1017/ash.2025.45 · Antimicrobial Stewardship & Healthcare Epidemiology : ASHE · 2025-02-24

## TL;DR

This study shows that screening and decolonization reduced MRSA infections in a neonatal intensive care unit.

## Contribution

The study demonstrates a sustained reduction in MRSA infections after implementing a screening and decolonization protocol in a NICU.

## Key findings

- The MRSA colonization rate was 2.2% from 2016 to 2022.
- A sustained downtrend in MRSA infection rates was observed after implementing the protocol.
- No MRSA-colonized neonates who received both mupirocin and CHG developed MRSA infection.

## Abstract

To determine the impact of screening and decolonization on methicillin-resistant Staphylococcus aureus (MRSA) infection in a neonatal intensive care unit.

This is a single-center retrospective cohort study comparing patient characteristics among MRSA-colonized and MRSA-infected infants, rates of MRSA infection before and after screening with targeted decolonization, and MRSA infection among those receiving single or combined decolonization agents.

Texas Children’s Hospital Pavilion for Women is a 42-bed level three neonatal intensive care units (NICU) in Houston, TX.

Neonates admitted to the NICU from 2012 to 2022 were included in analysis of MRSA colonization and infection. The gestational age ranged from 22 weeks to 42 weeks.

The MRSA screening methodology consisted of weekly surveillance PCR or culture on admission until discharge. If positive, infants underwent decolonization consisting of topical intranasal mupirocin, and if meeting the gestational and chronological age-based criteria, topical 2% chlorhexidine wipes and topical intranasal mupirocin.

The MRSA colonization rate from 2016 to 2022 was 2.2%. Following the screening and decolonization protocol initiated in 2016, there was a sustained downtrend in the rate of MRSA infection. No MRSA-colonized neonates who received both topical mupirocin and Chlorhexidine gluconate (CHG) developed MRSA infection.

We observed a decreased rate of MRSA infection in the NICU following implementation of an MRSA screening and decolonization protocol. While our data suggests that the combination of mupirocin and CHG might prevent infection, further studies are needed due to the low prevalence of MRSA infection in our cohort.

## Linked entities

- **Chemicals:** mupirocin (PubChem CID 446596), Chlorhexidine gluconate (PubChem CID 9552081), CHG (PubChem CID 66586232)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** MRSA (MESH:D013203), infected (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11869050/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11869050/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC11869050/full.md

---
Source: https://tomesphere.com/paper/PMC11869050